Cargando…
Reply to the letter from Blay et al: Pretreatment serum CRP and response to interleukin 2
| Autores principales: | , , |
|---|---|
| Formato: | Texto |
| Lenguaje: | English |
| Publicado: |
Nature Publishing Group
1994
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968783/ |
| _version_ | 1782134815872516096 |
|---|---|
| author | Heys, Steven D. Broom, John Eremin, Oleg |
| author_facet | Heys, Steven D. Broom, John Eremin, Oleg |
| author_sort | Heys, Steven D. |
| collection | PubMed |
| description | |
| format | Text |
| id | pubmed-1968783 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 1994 |
| publisher | Nature Publishing Group |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-19687832009-09-10 Reply to the letter from Blay et al: Pretreatment serum CRP and response to interleukin 2 Heys, Steven D. Broom, John Eremin, Oleg Br J Cancer Correspondence Nature Publishing Group 1994-01 /pmc/articles/PMC1968783/ Text en https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
| spellingShingle | Correspondence Heys, Steven D. Broom, John Eremin, Oleg Reply to the letter from Blay et al: Pretreatment serum CRP and response to interleukin 2 |
| title | Reply to the letter from Blay et al: Pretreatment serum CRP and response to interleukin 2 |
| title_full | Reply to the letter from Blay et al: Pretreatment serum CRP and response to interleukin 2 |
| title_fullStr | Reply to the letter from Blay et al: Pretreatment serum CRP and response to interleukin 2 |
| title_full_unstemmed | Reply to the letter from Blay et al: Pretreatment serum CRP and response to interleukin 2 |
| title_short | Reply to the letter from Blay et al: Pretreatment serum CRP and response to interleukin 2 |
| title_sort | reply to the letter from blay et al: pretreatment serum crp and response to interleukin 2 |
| topic | Correspondence |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1968783/ |
| work_keys_str_mv | AT heysstevend replytotheletterfromblayetalpretreatmentserumcrpandresponsetointerleukin2 AT broomjohn replytotheletterfromblayetalpretreatmentserumcrpandresponsetointerleukin2 AT ereminoleg replytotheletterfromblayetalpretreatmentserumcrpandresponsetointerleukin2 |